AI-Based Embryo Selection Explainability: Advances, Mechanisms, and Clinical Implications

Abstract

Artificial intelligence (AI) has revolutionized embryo selection in assisted reproductive technology (ART), enhancing implantation and pregnancy outcomes. However, the explainability of AI-based embryo selection remains a significant challenge, raising concerns among clinicians regarding transparency, reliability, and ethical use. This review explores the epidemiology of infertility necessitating embryo selection, the mechanisms underlying AI-based assessment, associated risk factors, clinical features of embryo viability, current diagnostic approaches, management strategies, and recent advances in explainable AI (XAI) for embryo selection. Evidence-based recommendations are discussed to bridge the gap between AI efficacy and clinical trust, providing practical insights for healthcare professionals engaged in reproductive medicine.

Introduction

In vitro fertilization (IVF) and other ART procedures have seen notable advancements in recent years, largely due to the integration of AI-driven technologies. Embryo selection is a critical determinant of ART success, traditionally reliant on morphological evaluation and time-lapse imaging. While conventional methods are subjective and prone to inter-observer variability, AI-based systems promise objective, reproducible, and data-driven embryo assessment. Nevertheless, the adoption of AI in clinical practice is hindered by a lack of explainability, with clinicians demanding transparency in AI decision-making to ensure patient safety and uphold ethical standards. This article systematically reviews the landscape of AI-based embryo selection, with a focus on the necessity, challenges, and solutions for explainable AI in clinical settings.

Epidemiology / Disease Burden

Infertility affects an estimated 10-15% of couples globally, with nearly 2.5 million ART cycles conducted annually worldwide. The demand for effective embryo selection strategies is driven by the need to optimize live birth rates while minimizing multiple pregnancies and associated complications. Despite advancements, the success rate per IVF cycle remains suboptimal, emphasizing the need for improved selection tools. AI models have demonstrated improved predictive accuracy for embryo viability, but widespread clinical adoption is limited by uncertainties regarding their interpretability and generalizability across diverse populations.

Pathophysiology

The success of embryo implantation hinges on complex interactions between embryo quality and endometrial receptivity. Embryo viability is influenced by genetic, epigenetic, and morphological parameters, with aneuploidy being a leading cause of implantation failure and miscarriage. AI-based systems analyze high-dimensional data, such as time-lapse imaging and -omics profiles, to identify subtle patterns associated with developmental competence. However, the underlying decision-making process of deep neural networks is often opaque, necessitating explainability frameworks to elucidate the relationship between input features and selection outcomes.

Risk Factors

Key risk factors impacting embryo selection and ART outcomes include advanced maternal age, diminished ovarian reserve, male factor infertility, and suboptimal culture conditions. AI-based selection tools must account for these patient-specific variables to deliver personalized predictions. Importantly, bias in training data or algorithm design may inadvertently propagate health disparities if not adequately addressed by explainable and audited models, underscoring the clinical imperative for transparency in AI-driven recommendations.

Clinical Features

Traditional embryo selection relies on morphological features such as cell symmetry, fragmentation, and developmental timing. AI algorithms extend this assessment by integrating quantitative imaging metrics, kinetic parameters, and, in some cases, genetic data. Explainable AI aims to highlight which features most significantly influence selection, enabling clinicians to validate AI recommendations against established embryological knowledge and clinical experience.

Diagnosis

AI-based diagnostic tools leverage supervised and unsupervised learning to classify embryos according to implantation potential. Methods include convolutional neural networks (CNNs) for image analysis and ensemble models incorporating clinical and laboratory data. Explainability is achieved through techniques like saliency maps, SHAP (Shapley Additive Explanations), and LIME (Local Interpretable Model-agnostic Explanations), which visually or quantitatively attribute decision weightings to input features, supporting clinician interpretation and informed clinical discussions with patients.

Treatment & Management

The integration of explainable AI in embryo selection transforms clinical management by providing actionable insights into embryo viability and optimizing individualized treatment plans. Clinicians can use AI-generated explanations to justify or question embryo transfer decisions, improving patient counseling and shared decision-making. Moreover, explainability fosters trust and regulatory compliance, essential for the responsible deployment of AI in high-stakes reproductive medicine.

Recent Advances / Emerging Therapies

Recent research has focused on enhancing the explainability of AI models through hybrid approaches combining data-driven analytics with rule-based reasoning rooted in embryological principles. Novel XAI frameworks enable real-time feedback on feature importance, confidence intervals, and model uncertainty, facilitating adaptive learning and quality assurance. Emerging therapies leveraging multi-modal data fusion—such as integrating time-lapse imaging, metabolomics, and genomics—are poised to further improve accuracy and explainability. Additionally, collaborative efforts between clinicians, data scientists, and ethicists are shaping guidelines for transparent and accountable AI deployment in ART.

Guideline Recommendations

Societies such as the American Society for Reproductive Medicine (ASRM) and European Society of Human Reproduction and Embryology (ESHRE) emphasize the importance of transparency, validation, and clinician oversight in AI-assisted embryo selection. Key recommendations include external validation of AI models, routine explainability audits, stakeholder education, and the integration of patient values in decision-making. Regulatory bodies advocate for explainable AI as a prerequisite for clinical adoption, safeguarding against algorithmic bias and ensuring equitable access to advanced reproductive technologies.

Conclusion

AI-based embryo selection represents a paradigm shift in ART, offering unprecedented accuracy and efficiency. However, explainability remains a cornerstone for clinical acceptance, regulatory compliance, and ethical practice. By advancing explainable AI frameworks, fostering interdisciplinary collaboration, and adhering to evolving guidelines, clinicians can harness the full potential of AI while ensuring patient-centered, transparent, and accountable care in reproductive medicine.